[Elsevier] Effect of the Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Evolocumab on Glycemia, Body Weight, and New-Onset Diabetes Mellitus

Mos272 Post time 2024-5-4 19:02:55 | Show all posts |Read mode
Reward10points

journal:The American Journal of Cardiology

Authors:Naveed Sattar; Peter P. Toth; Dirk J. Blom; Michael J. Koren; Handrean Soran; Magdalena Uhart; Mary Elliott; Marcoli Cyrille; Ransi Somaratne; David Preiss

Published date:2017-11-

DOI:10.1016/j.amjcard.2017.07.047

PDF link:https://www.sciencedirect.com/sc ... 002914917312201/pdf

Article link:http://dx.doi.org/10.1016/j.amjcard.2017.07.047

Article Source:Elsevier BV


Remark:

Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
AradDeh Post time 2024-5-4 19:02:56 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    1065

Latest Reply

Return to the list